Skip to primary navigation
Skip to main content
Skip to footer

Fractyl Health

Transformative Metabolic Therapies

Investors
Clinical Studies
Careers

Our Focus
- Obesity
- Type 2 Diabetes
Our Platforms
- Revita
- Rejuva
Our Science
- Clinical Studies
- Presentations & Publications
Our Company
- Culture
- Our Team
- Careers
Our News

Home/Obesity

Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves Metabolism in Obese Mice

Obesity

November 4, 2024 by

November 3, 2024 by

Footer

LinkedIn X, formally Twitter Facebook

© 2014-2024 Fractyl Health, Inc. All Rights Reserved.

Contact
Privacy & Cookie Policy
Terms of Use
Intellectual Property
Transparency in Coverage

Our Focus
- Obesity
- Type 2 Diabetes
Our Platforms
- Revita
- Rejuva
Our Science
- Clinical Studies
- Presentations & Publications
Our Company
- Culture
- Our Team
- Careers
Our News
Investors